KURA ONCOLOGY INC. -
11.17
27-November-24 16:45:00
15 minutes delayed
Stocks
+0.42
+3.91%
Today's range
10.71 - 11.44
ISIN
N/A
Source
NASDAQ
-
Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia
24 Nov 2021 06:45:00 By Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Two Upcoming Investor Conferences
23 Nov 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology Reports Third Quarter 2021 Financial Results
04 Nov 2021 16:05:02 By Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Credit Suisse Healthcare Conference
02 Nov 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology to Report Third Quarter 2021 Financial Results
28 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology Appoints Teresa Bair as Chief Legal Officer
18 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Two Upcoming Investor Conferences
07 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology Reports Second Quarter 2021 Financial Results
05 Aug 2021 16:05:02 By Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Wedbush PacGrow Healthcare Virtual Conference
04 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology to Report Second Quarter 2021 Financial Results
29 Jul 2021 16:05:01 By Nasdaq GlobeNewswire
-
Kura Oncology Appoints Helen Collins, M.D. to Board of Directors
29 Jul 2021 07:30:00 By Nasdaq GlobeNewswire
-
06 Jul 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology Doses First Patient in Phase 1b Expansion Cohorts with Menin Inhibitor KO-539
24 Jun 2021 08:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology to Participate in JMP Securities Life Sciences Conference
10 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology Appoints Carol Schafer to Board of Directors
04 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology to Participate in Cowen Virtual Oncology Innovation Summit
13 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology Reports First Quarter 2021 Financial Results
06 May 2021 16:04:00 By Nasdaq GlobeNewswire
-
Kura Oncology to Report First Quarter 2021 Financial Results
29 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
-
Kura Oncology Announces Publication of Tipifarnib Phase 2 Data in Journal of Clinical Oncology
22 Mar 2021 16:08:47 By Nasdaq GlobeNewswire
-
Kura Oncology Reports Fourth Quarter and Full Year 2020 Financial Results
24 Feb 2021 07:20:00 By Nasdaq GlobeNewswire